Accuracy of 2-hydroxyglutarate quantification by short-echo proton-MRS at 3 T: A phantom study

Physica Medica

Volumn 30, Issue 6, 2014, Pages 702-707

  Bertolino, Nicola ^a   Marchionni, Chiara ^b   Ghielmetti, Francesco ^a   Burns, Brian ^c   Finocchiaro, Gaetano ^a   Anghileri, Elena ^a   Bruzzone, Maria Grazia ^a   Minati, Ludovico ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b NERVIANO MEDICAL SCIENCES   (Italy)

^c Engineering IV   (United States)

Author keywords

2 Hydroxyglutarate (2HG); Accuracy; Brain; Glioma; Magnetic resonance spectroscopy (MRS)

Indexed keywords

2 HYDROXYGLUTARIC ACID; GLUTAMIC ACID; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; N ACETYLASPARTIC ACID; ALPHA-HYDROXYGLUTARATE; ASPARTIC ACID; GLUTARIC ACID DERIVATIVE; ISOCITRATE DEHYDROGENASE; N-ACETYLASPARTATE;

ACCURACY; ARTICLE; CONCENTRATION (PARAMETERS); GENE MUTATION; GLIOMA; IDH 1 GENE; IDH 2 GENE; MAGNETIC FIELD; METABOLITE; NUCLEAR MAGNETIC RESONANCE SCANNER; PHANTOM; PROTON NUCLEAR MAGNETIC RESONANCE; ANALOGS AND DERIVATIVES; BRAIN; DEVICES; ENZYMOLOGY; GENETICS; HUMAN; IMAGE QUALITY; METABOLISM; MUTATION;

FALCONIDAE;

ASPARTIC ACID; BRAIN; GLIOMA; GLUTAMIC ACID; GLUTARATES; HUMANS; ISOCITRATE DEHYDROGENASE; MUTATION; PHANTOMS, IMAGING; PROTON MAGNETIC RESONANCE SPECTROSCOPY;

EID: 84906234988     PISSN: 11201797     EISSN: 1724191X     Source Type: Journal    
DOI: 10.1016/j.ejmp.2014.03.002     Document Type: Article

References (24)

1. Grier J.T., Batchelor T. Low-grade gliomas in adults. Oncologist 2006, 11(6):681-693.
2. Wick W., Meisner C., Hentschel B., Platten M., Schilling A., Wiestler B., et al. Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation. Neurology 2013, [epub ahead of print].
3. Baldewpersad Tewarie N.M., Burgers I.A., Dawood Y., den Boon H.C., den Brok M.G., Klunder J.H., et al. NADP+ -dependent IDH1 R132 mutation and its relevance for glioma patient survival. Med Hypotheses 2013, 80(6):728-731.
4. Parsons D.W., Jones S., Zhang X., Lin J.C., Leary R.J., Angenendt P., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321(5897):1807-1812.
5. Zhao S., Lin Y., Xu W., Jiang W., Zha Z., Wang P., et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 2009, 324(5924):261-265.
6. Yan H., Parsons D.W., Jin G., McLendon R., Rasheed B.A., Yuan W., et al. IDH1 and IDH2 mutations in gliomas. NEngl J Med 2009, 360(8):765-773.
7. Choi C., Ganji S.K., DeBerardinis R.J., Hatanpaa K.J., Rakheja D., Kovacs Z., et al. 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat Med 2012, 18(4):624-629.
8. Elkhaled A., Jalbert L.E., Phillips J.J., Yoshihara H.A., Parvataneni R., Srinivasan R., et al. Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas. Sci Transl Med 2012, 4(116):116ra5.
9. Pope W.B., Prins R.M., Albert Thomas M., Nagarajan R., Yen K.E., Bittinger M.A., et al. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. JNeurooncol 2012, 107(1):197-205.
10. Andronesi O.C., Kim G.S., Gerstner E., Batchelor T., Tzika A.A., Fantin V.R., et al. Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by invivo spectral-editing and 2D correlation magnetic resonance spectroscopy. Sci Transl Med 2012, 4(116):116ra4.
11. Choi C., Ganji S., Hulsey K., Madan A., Kovacs Z., Dimitrov I., et al. Acomparative study of short- and long-TE 1 H MRS at 3 T for invivo detection of 2-hydroxyglutarate in brain tumors. NMR Biomed 2013, 26(10):1242-1250.
12. Kalinina J., Carroll A., Wang L., Yu Q., Mancheno D.E., Wu S., et al. Detection of "oncometabolite" 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma. JMol Med (Berl) 2012, 90(10):1161-1171.
13. Esteve V., Celda B., Martinez-Bisbal M.C. Use of 1H and 31P HRMAS to evaluate the relationship between quantitative alterations in metabolite concentrations and tissue features in human brain tumour biopsies. Anal Bioanal Chem 2012, 403(9):2611-2625.
14. Florian C.L., Preece N.E., Bhakoo K.K., Williams S.R., Noble M.D. Cell type-specific fingerprinting of meningioma and meningeal cells by proton nuclear magnetic resonance spectroscopy. Cancer Res 1995, 55(2):420-427.
15. Minati L., Aquino D., Bruzzone M.G., Erbetta A. Quantitation of normal metabolite concentrations in six brain regions by in-vivo 1H-MR spectroscopy. JMed Phys 2010, 35(3):154-163.
16. Provencher S.W. Estimation of metabolite concentrations from localized invivo proton NMR spectra. Magn Reson Med 1993, 30(6):672-679.
17. Smith S.A., Levante T.O., Meier B.H., Ernst R.R. Computer simulations in magnetic resonance. An Object-Oriented Programming approach. JMagn Reson 1994, 106(1):75-105.
18. Gonsalves R.A. Cramér-Rao bounds on mensuration errors. Appl Opt 1976, 15(5):1270-1275.
19. DeBerardinis R.J., Mancuso A., Daikhin E., Nissim I., Yudkoff M., Wehrli S., et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A 2007, 104(49):19345-19350.
20. Kallenberg K., Bock H.C., Helms G., Jung K., Wrede A., Buhk J.H., et al. Untreated glioblastoma multiforme: increased myo-inositol and glutamine levels in the contralateral cerebral hemisphere at proton MR spectroscopy. Radiology 2009 Dec, 253(3):805-812.
21. Jalbert L.E., Elkhaled A., Philips J.J., Chang S.M., Nelson S.J. Image-guided metabolomic analysis of 2-hydroxyglutarate in IDH-mutant gliomas. Proc Intl Soc Mag Reson Med 2013, 21. #6334.
22. Mazzetti S., Bracco C., Regge D., Caivano R., Russo F., Stasi M. Choline-containing compounds quantification by (1)H NMR spectroscopy using external reference and noise measurements. Phys Med 2013, 29(6):677-683.
23. Cudalbu C., Cavassila S., Rabeson H., van Ormondt D., Graveron-Demilly D. Influence of measured and simulated basis sets on metabolite concentration estimates. NMR Biomed 2008, 21(6):627-636.
24. 1H MRS data at 1.5 T. NMR Biomed 2010, 23(10):1117-1126.